Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC17255398;5399;5400 chr2:178776691;178776690;178776689chr2:179641418;179641417;179641416
N2AB17255398;5399;5400 chr2:178776691;178776690;178776689chr2:179641418;179641417;179641416
N2A17255398;5399;5400 chr2:178776691;178776690;178776689chr2:179641418;179641417;179641416
N2B16795260;5261;5262 chr2:178776691;178776690;178776689chr2:179641418;179641417;179641416
Novex-116795260;5261;5262 chr2:178776691;178776690;178776689chr2:179641418;179641417;179641416
Novex-216795260;5261;5262 chr2:178776691;178776690;178776689chr2:179641418;179641417;179641416
Novex-317255398;5399;5400 chr2:178776691;178776690;178776689chr2:179641418;179641417;179641416

Information

  • RefSeq wild type amino acid: R
  • RefSeq wild type transcript codon: AGG
  • RefSeq wild type template codon: TCC
  • Domain: Ig-8
  • Domain position: 23
  • Structural Position: 34
  • Q(SASA): 0.3555
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
R/S None None 1.0 D 0.769 0.441 0.276482976112 gnomAD-4.0.0 1.59066E-06 None None None None I None 0 0 None 0 0 None 0 0 2.85652E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
R/A 0.9639 likely_pathogenic 0.9676 pathogenic -0.982 Destabilizing 0.999 D 0.613 neutral None None None None I
R/C 0.7804 likely_pathogenic 0.7994 pathogenic -0.887 Destabilizing 1.0 D 0.761 deleterious None None None None I
R/D 0.9911 likely_pathogenic 0.9921 pathogenic -0.12 Destabilizing 1.0 D 0.773 deleterious None None None None I
R/E 0.9364 likely_pathogenic 0.94 pathogenic 0.052 Stabilizing 0.999 D 0.608 neutral None None None None I
R/F 0.9539 likely_pathogenic 0.9589 pathogenic -0.507 Destabilizing 1.0 D 0.767 deleterious None None None None I
R/G 0.9575 likely_pathogenic 0.9639 pathogenic -1.346 Destabilizing 1.0 D 0.743 deleterious D 0.604984936 None None I
R/H 0.437 ambiguous 0.453 ambiguous -1.544 Destabilizing 1.0 D 0.731 prob.delet. None None None None I
R/I 0.8606 likely_pathogenic 0.889 pathogenic 0.024 Stabilizing 1.0 D 0.773 deleterious None None None None I
R/K 0.5604 ambiguous 0.5594 ambiguous -0.883 Destabilizing 0.997 D 0.456 neutral N 0.49718559 None None I
R/L 0.8142 likely_pathogenic 0.8276 pathogenic 0.024 Stabilizing 1.0 D 0.743 deleterious None None None None I
R/M 0.9287 likely_pathogenic 0.9375 pathogenic -0.406 Destabilizing 1.0 D 0.779 deleterious D 0.669402298 None None I
R/N 0.9771 likely_pathogenic 0.9794 pathogenic -0.502 Destabilizing 1.0 D 0.732 prob.delet. None None None None I
R/P 0.993 likely_pathogenic 0.9945 pathogenic -0.291 Destabilizing 1.0 D 0.758 deleterious None None None None I
R/Q 0.5093 ambiguous 0.5173 ambiguous -0.533 Destabilizing 1.0 D 0.729 prob.delet. None None None None I
R/S 0.966 likely_pathogenic 0.9707 pathogenic -1.305 Destabilizing 1.0 D 0.769 deleterious D 0.543621239 None None I
R/T 0.9314 likely_pathogenic 0.9397 pathogenic -0.923 Destabilizing 1.0 D 0.753 deleterious N 0.498695794 None None I
R/V 0.8904 likely_pathogenic 0.9073 pathogenic -0.291 Destabilizing 1.0 D 0.769 deleterious None None None None I
R/W 0.7638 likely_pathogenic 0.765 pathogenic -0.09 Destabilizing 1.0 D 0.751 deleterious D 0.670055379 None None I
R/Y 0.8951 likely_pathogenic 0.8997 pathogenic 0.145 Stabilizing 1.0 D 0.781 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.